- Before
- Keeps 61 playbooks current across seven regions, assembling them by hand and guessing which ones an SOP change touches. “Tell me which playbooks a change touches — and only show me what changed.”
- Now
- Sees the 12 affected playbooks on the matrix, reviews the one changed section and signs once; 34 account editions go live for 216 reps.
One SOP change, from approval to every playbook live in CRM
Tuesday 6 October 2026. Lena Ortiz, commercial excellence lead, owns the German playbooks. The field teams sell three products — Veltrimab, a biologic for Crohn's disease and ulcerative colitis, Corventa for chronic heart failure, and the Talmirex infusion pump. At 09:14 a new version of the product handling SOP is approved. Here is what happens next, screen by screen, in the working solution.
- 0109:14
Every playbook on one matrix, and a new SOP at the top
Lena Ortiz · Commercial excellence leadThe playbook matrix shows 61 playbooks and 146 account editions live in CRM: seven regions down, three products and their audiences across. Each cell shows its age, version, account editions and one square per source — product information first, then each SOP. Four cells are amber: the Veltrimab product information changed on 1 October. Above the matrix, SOP-COM-031 Communicating product handling, version 5, approved by Dr. Maya Chen.
“Built into 12 playbooks (34 account editions): Veltrimab · pharmacist and infusion nurse in 6 European regions.”
- 02Already flagged
Four playbooks still quote the old stability wording
Freshness checkerThe playbooks list shows the earlier change too. Section 6.3 of the Veltrimab product information now says 8 hours at room temperature after dilution, where version 6 said 4. The freshness checker found the four live playbooks that quote the old wording — PB-2038 Germany · Infusion nurse, PB-2033 Italy, PB-2031 Spain and PB-2027 UK · Hospital pharmacist — and marked them Refresh needed.
“4 live playbooks quote the old wording; the content freshness checker found them.”
- 03What changed
One new line in section 5.2
Lena Ortiz · Commercial excellence leadLena opens the change. Version 4, effective 2 June, is superseded today; version 5 was approved by Dr. Maya Chen for Quality and Medical. Section 5.2 gains one sentence: if a healthcare professional reports product exposed outside the labelled storage, the rep also records a product quality complaint in CRM within 24 hours, with the lot number and, if known, the temperature and how long.
“Sections 5.1 and 5.3 are unchanged. Only playbooks built from this SOP are affected — the matrix shows which.”
- 04One click
“Rebuild affected playbooks” — 12 cells, one section each
Freshness checker and Playbook assemblerThe freshness checker reads version 5 and finds the 12 playbooks built from SOP-COM-031 in Germany, France, Spain, Italy, the United Kingdom and the Nordics; the US playbooks use SOP-US-031 and are untouched. The assembler rebuilds only Storage and handling and keeps every other section word for word; the four amber cells also pick up product information version 7 (“Storage +1”). The compliance check passes, and the cells turn blue: rebuilt, waiting for sign-off.
“Waiting for your sign-off — nothing reaches CRM until it is signed.”
- 05Germany · pharmacist
A rep's question, answered with the SOP line
SOP assistantIn the Germany · Veltrimab hospital pharmacist cell Lena tries the question reps actually get: “A pen was left out for 6 weeks — what do I do?” The answer opens with the new line of SOP-COM-031 version 5, quoted. It is a medical question, so the rep does not say whether the pen can be used; they record a product quality complaint within 24 hours with the lot number, submit a medical information request with the pharmacist's consent, and replacement requests go to Customer Service, never through the rep.
SOP assistant · 2 passages from 2 documents · 0.9 s
- 06Signed once
One signature publishes 34 account editions
Lena Ortiz · Playbook ownerThe sign-off shows what she is signing: only the changed section differs, the compliance check passed in all 12, and 34 account editions go to 216 reps on the account tab and the next call plan. She signs with her password and the reason “SOP update — approved for field use”. The CRM publisher replaces the 34 editions and keeps the previous versions in history.
“Reps asking about a warm pen now get the new complaint step with its SOP line.”
- 07A new account
Pick the market, the product and the person the rep will meet
Lena Ortiz · Commercial excellence leadNext she starts a playbook for Klinikum Rheinhafen: Germany (58 reps), Veltrimab, hospital pharmacist. 38 approved modules match, all in date. Three are left out — DE-VEL-0371, expired 30 September; DE-VEL-0388, withdrawn with the old stability wording; US-VEL-0207, approved for the US only — and the German Pflichttext is added.
- 08A few seconds later
Nine sections, each with its sources
Playbook assemblerPB-2047 is assembled from 10 modules, wording unchanged. It opens with the account from CRM: 1,150 beds, an IBD centre, the drug committee on 22 October, and the last call on 18 September asking whether pens can be kept as ward stock at room temperature — answered in section 3. Storage and handling already carries the version 5 line. The compliance check passes; it waits for Lena's sign-off.
“Built only from approved, in-date modules — wording is unchanged, so Medical and Legal approval carries over.”
- 09The rep's view
What the rep sees on the account in CRM
Jonas Weber · Hospital rep, GermanyBefore signing, Lena checks the rep view: the approved opening line, the talking points, a “Stay on label” box, the storage card, chair-time visual and follow-up email to share, and the SOP assistant beside them. Jonas Weber has it on his call plan for 14 October, 10:30.
“Stay on label: children, off-label doses and storage outside the label → medical information request in CRM.”
- 1008:15 that morning
Off-label goes to Medical Information
SOP assistantMiriam Kraus, a rep in Germany, asked whether she could answer a pharmacist's question about use in children. The assistant said no: Veltrimab is approved for adults only, and field colleagues never answer off-label questions. It quoted SOP-MED-022 section 3.3, told her to capture the question word for word with consent, and offered to log the medical information request. The question is marked Routed.
“Field colleagues never answer off-label questions themselves, including use in patients under 18, doses or intervals outside the label, or combinations not studied.” — SOP-MED-022, version 9